Federated Hermes
RAPT

Federated Hermes’s RAPT Therapeutics RAPT Stock Holding History

Federated Hermes’s Portfolio RAPT Stock Details RAPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-136
Closed -$1.09K – 2208
2025
Q2 		$1.09K Sell
136
-25,036
-99% -$191K ﹤0.01% 1994
2025
Q1 		$246K Sell
25,172
-75,155
-75% -$739K ﹤0.01% 1463
2024
Q4 		$1.27M Buy
100,327
+330
+0.3% +$4.19K ﹤0.01% 1043
2024
Q3 		$1.61M Buy
99,997
+487
+0.5% +$9.85K ﹤0.01% 991
2024
Q2 		$2.43M Buy
99,510
+65,046
+189% +$3M 0.01% 888
2024
Q1 		$2.48M Buy
+34,464
New +$4.79M 0.01% 878
2023
Q2 		– Sell
-2,189
Closed -$321K – 2207
2023
Q1 		$321K Buy
+2,189
New +$443K ﹤0.01% 1510
2021
Q4 		– Sell
-8
Closed -$2K – 2289
2021
Q3 		$2K Buy
+8
New +$2.12K ﹤0.01% 2101
2020
Q2 		– Sell
-82
Closed -$14K – 2349
2020
Q1 		$14K Buy
+82
New +$18.7K ﹤0.01% 1829

Other funds holding RAPT

MVM
Medicxi Ventures Management St. Helier, Jersey $177M AUM 212.06% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
FCMV
Foresite Capital Management VI Larkspur, California $643M AUM 343.43% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
BCM
Boone Capital Management Atlanta, Georgia $428M AUM 136.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

Federated Hermes's RAPT Position: Q3 2025 in Review

Federated Hermes sold out of RAPT Therapeutics (RAPT) in Q3 2025, closing a stake of 136 shares — an estimated $1.09K sold.

Federated Hermes first reported a position in RAPT in Q1 2020 and held it in 9 quarters. The position peaked at $2.48M in Q1 2024. 65 funds tracked by Wall St. Rank hold RAPT as of Q3 2025.

  • Federated Hermes reported no remaining RAPT Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Federated Hermes sold 136 RAPT Therapeutics shares in Q3 2025, an estimated $1.09K.
  • Federated Hermes first reported a position in RAPT Therapeutics in Q1 2020 and held it in 9 quarters.
  • Federated Hermes's RAPT Therapeutics position peaked at $2.48M in Q1 2024.
  • 65 funds tracked by Wall St. Rank held RAPT Therapeutics as of Q3 2025.

Based on Federated Hermes's 13F filing for Q3 2025, filed 3 Nov 2025.